Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly

American Journal of Infection Control

Volumn 44, Issue 1, 2016, Pages 50-53

  Lorente, Leonardo ^a   Lecuona, María ^a   Jiménez, Alejandro ^a   Raja, Lorena ^a   Cabrera, Judith ^a   Gonzalez, Oswaldo ^a   Diosdado, Sara ^a   Marca, Lucía ^a   Mora, María L ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Bacteremia; Central venous catheter; Chlorhexidine; Impregnated catheter; Silver sulfadiazine

Indexed keywords

CHLORHEXIDINE; MICONAZOLE; RIFAMPICIN; SULFADIAZINE SILVER; ANTIINFECTIVE AGENT;

ADULT; AGED; APACHE; ARTICLE; CATHETER INFECTION; CHLORHEXIDINE SILVER SULFADIAZINE IMPREGNATED CATHETER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEVICE COMPARISON; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INFECTION RATE; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RIFAMPICIN MICONAZOLE IMPREGNATED CATHETER; ADVERSE DEVICE EFFECT; BACTEREMIA; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COMPARATIVE STUDY; INTENSIVE CARE UNIT; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RISK;

AGED; ANTI-INFECTIVE AGENTS; BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MICONAZOLE; MIDDLE AGED; RETROSPECTIVE STUDIES; RIFAMPIN; RISK; SILVER SULFADIAZINE;

EID: 84954078528     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.08.014     Document Type: Article

References (28)

1. J.L. Vincent, D.J. Bihari, P.M. Suter, H.A. Bruining, J. White, M.H. Nicolas-Chanoin, and et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee JAMA 274 1995 639 644
2. D. Pittet, D. Tarara, and R.P. Wenzel Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598 1601
3. J.B. Dimick, R.K. Pelz, R. Consunji, S.M. Swoboda, C.W. Hendrix, and P.A. Lipsett Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit Arch Surg 136 2001 229 234
4. I.I. Siempos, P. Kopterides, I. Tsangaris, I. Dimopoulou, and A.E. Armaganidis Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis Crit Care Med 37 2009 2283 2289
5. M.L. Lambert, C. Suetens, A. Savey, M. Palomar, M. Hiesmayr, I. Morales, and et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study Lancet Infect Dis 11 2011 30 38
6. K.B. Laupland, H. Lee, D.B. Gregson, and B.J. Manns Cost of intensive care unit-acquired bloodstream infections J Hosp Infect 63 2006 124 132
7. D.L. Veenstra, S. Saint, S. Saha, T. Lumley, and S.D. Sullivan Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis JAMA 281 1999 261 267
8. M.E. Falagas, K. Fragoulis, I.A. Bliziotis, and I. Chatzinikolaou Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials J Antimicrob Chemother 59 2007 359 369
9. Hockenhull JC, Dwan K, Boland A,SmithG, BagustA, DündarY et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess. 2008;12:iii-iv, xi-xii, 1-154.
10. P. Ramritu, K. Halton, P. Collignon, D. Cook, D. Fraenkel, D. Battistutta, and et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units Am J Infect Control 36 2008 104 117
11. H. Wang, T. Huang, J. Jing, J. Jin, P. Wang, M. Yang, and et al. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis J Hosp Infect 76 2010 1 11
12. P.E. Marik, G. Abraham, P. Careau, J. Varon, and R.E. Fromm Jr. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters Crit Care Med 27 1999 1128 1131
13. R.O. Darouiche, I.I. Raad, S.O. Heard, J.I. Thornby, O.C. Wenker, A. Gabrielli, and et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group N Engl J Med 340 1999 1 8
14. D.G. Maki, C.E. Weise, and H.W. Sarafin A semiquantitative culture method for identifying intravenous catheter-related infection N Engl J Med 296 1977 1305 1309
15. L. Lorente, C. Henry, M.M. Martín, A. Jiménez, and M.L. Mora Central venous catheter-related infection in a prospective and observational study of 2595 catheters Crit Care 9 2005 631 635
16. L. Lorente, M. Lecuona, M.J. Ramos, A. Jiménez, M.L. Mora, and A. Sierra The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia Clin Infect Dis 47 2008 1171 1175
17. L. Lorente, M. Lecuona, M.J. Ramos, A. Jiménez, M.L. Mora, and A. Sierra Lower assistance costs using rifampicin-miconazole-impregnated catheters than standard catheters Am J Infect Control 39 2011 895 897
18. L. Lorente, M. Lecuona, M.J. Ramos, A. Jiménez, M.L. Mora, and A. Sierra Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy Eur J Clin Microbiol Infect Dis 3 2012 1833 1836
19. L. Lorente, M. Lecuona, A. Jiménez, R. Santacreu, L. Raja, O. González, and et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs Am J Infect Control 42 2014 321 324
20. L. Lorente, M. Lecuona, A. Jiménez, L. Lorenzo, S. Diosdado, L. Marca, and et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access Am J Infect Control 42 2014 1130 1132
21. L. Lorente, M. Lecuona, A. Jiménez, L. Lorenzo, R. Santacreu, S. Ramos, and et al. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian site Am J Infect Control 43 2015 711 714
22. N.P. O'Grady, M. Alexander, L.A. Burns, E.P. Dellinger, J. Garland, S.O. Heard, and et al. Guidelines for the prevention of intravascular catheter-related infections Am J Infect Control 39 Suppl 2011 S1 S34
23. T. Oda, J. Hamasaki, N. Kanda, and K. Mikami Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter Anesthesiology 87 1997 1242 1244
24. E. Terazawa, H. Shimonaka, K. Nagase, T. Masue, and S. Dohi Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter Anesthesiology 89 1998 1296 1298
25. R. Stephens, M. Mythen, P. Kallis, D.W. Davies, W. Egner, and A. Rickards Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter Br J Anaesth 87 2001 306 308
26. R. Jee, L. Nel, G. Gnanakumaran, A. Williams, and E. Eren Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg? Br J Anaesth 103 2009 614 615
27. L.A. Sampath, S.M. Tambe, and S.M. Modak In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters Infect Control Hosp Epidemiol 22 2001 640 646
28. S.M. Tambe, L. Sampath, and S.M. Modak In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices J Antimicrob Chemother 47 2001 589 598